First step into the U.S. market

Particle3D receives investment from New York based venture capital firm, Asimov Ventures, and enters valuable U.S. partnership. The partnership with Asimov Ventures marks the Company’s first step into the U.S. market, looking toward an early commercialization of P3D Bone in the USA.

Asimov Ventures invests in technology, including but not limited to 3D printing, and GP Tyler Benster says: “Particle3D impressed with its next-generation technology for 3D printing bone. Orthopedic implants have been a major engine of growth for additive manufacturing, although today, these implants are largely produced in titanium. Particle3D’s technology uses calcium phosphate, the same mineral as natural bone. Although there are regulatory milestones ahead to prove that this process is safe, we chose Particle3D as the winner of this year’s Additive Manufacturing Strategies’ startup competition given the massive market opportunity as well as benefit to mankind at large for safer bone implants”. 

“We are looking forward to initiate this collaboration with Asimov Ventures which aims to advance the Company’s commercialization activities in the U.S.”, said Thea Wulff Olesen, CEO of Particle3D.

The partnership follows Particle3D’s attendance at the third annual Additive Manufacturing Strategies summit in Boston earlier this year, where the Company won the AMS Startup Competition.

Particle3D is grateful for the recognition and validation of the Company and its technology in the USA, which demonstrates a great market potential for the P3D Bone implant.

For further information, please contact:
Thea Wulff Olesen, CEO
Email: TWO@Particle3D.com

 

About Particle3D

Particle3D is a Danish MedTech company founded on proprietary technology to 3D print patient specific, natural and resorbable bone implants. This enables fast ingrowth on bone tissue, remodeling into real living bone, and results in fewer complications. The technology can also be used for 3D printed R&D products, implants with additives, such as antibiotics or other drugs, and even in industries outside healthcare. Website Particle3D – We Print Bone.

 

More from our Blog and Newsroom

Patent for Particle3D’s technology granted in China

Patent for Particle3D’s technology granted in China

Chinese Patent Granted for Particle3D's 3D printing technology August 10th 2021, the China National Intellectual Property Administration (CNIPA) announced that Particle3D's patent, Feedstock for 3D printing and uses thereof no. PCT/DK2016/050323, has been granted in...

What 3D printing is all about

What 3D printing is all about

3D printing may sound like something from a galaxy far, far away, but the technology has been around for quite some time. Throughout the years, scientists from all over the world have printed everything; from small food items to large scale houses, and in the medical...

Particle3D – New market-oriented Chairman of the Board

Particle3D – New market-oriented Chairman of the Board

                        Particle3D ApSOslogade 15000 Odense C Denmark Press Release   Particle3D – New market-oriented Chairman of the Board ODENSE, 1st June 2021 – Particle3D, We Print Bone™, is pleased to announce that a new and highly qualified Chairman of the...